Add Company
Join Now

AgoMab Revenue and Competitors

License our Company Data API

Ghent,

Location

#3321

Growjo Ranking

Biotech

Industry
Embed

Estimated Revenue & Valuation

  • AgoMab's estimated annual revenue is currently $15.5M per year.(i)
  • AgoMab's estimated revenue per employee is $189,024
  • AgoMab's total funding is $333M.

Employee Data

  • AgoMab has 82 Employees.(i)
  • AgoMab grew their employee count by 32% last year.

AgoMab's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head Preclinical SafetyReveal Email/Phone
3
General CounselReveal Email/Phone
4
Chief Medical OfficerReveal Email/Phone
5
DMPK managerReveal Email/Phone
6
Manager BioanalysisReveal Email/Phone
7
Project Manager Early DevelopmentReveal Email/Phone
8
Research And Development ChemistReveal Email/Phone
9
Químico de investigación y desarrolloReveal Email/Phone
10
Senior ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$99.4M45840%N/AN/A
#2
$20.6M13322%N/AN/A
#3
$156.1M146-70%$145MN/A
#4
$3.5M45-25%$150MN/A
#5
$1.6M210%$459.5MN/A
#6
$67.3M31016%$180.7MN/A
#7
$8.5M55-2%N/AN/A
#8
$256.3M10259%$168.5MN/A
#9
$2.8M18-33%N/AN/A
#10
$9.1M59-9%N/AN/A
Add Company

What Is AgoMab?

AgomAb is developing molecular therapies for the regeneration of damaged tissues. Our unique agonistic monoclonal antibody molecules (“agomAbs”) stimulate molecular and cellular repair mechanisms that have the potential to restore organ function in patients with fibrotic, inflammatory, autoimmune and degenerative diseases.

keywords:N/A

$333M

Total Funding

82

Number of Employees

$15.5M

Revenue (est)

32%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13M84-3%N/A
#2
$7.5M86-20%N/A
#3
$13.8M8927%N/A
#4
$24.1M9528%N/A
#5
$14.1M1016%$48M